TP53 and non-small cell lung carcinoma: To meet the metabolic demands of rapid proliferation, the process involves generating aberrant vasculature and consuming oxygen at the early stage of tumor progression.[48] In particular, mutant p53 cooperates with HIF-1 as a promoter of non-small-cell lung cancer progression by hypoxic conditions.[49]